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Expression of a monoclonal antibody (3G5) defined ganglioside antigen
in the renal cortex. The monoclonal antibody (mAb) 305 was found, by
indirect immunofluorescence, to bind to renal cortical structures in
frozen sections of human, rat and calf kidneys. Double indirect immu-
nofluorescence studies on frozen sections of rat kidneys showed that
305 stained only the glomerulus and the distribution of the 305 antigen
on the glomerulus was more extensive than the staining observed with
antibodies to Factor VIII antigen. 305 stained the proximal convoluted
tubules and collecting tubules in bovine renal sections but glomeruli did
not stain with 305. The 305 mAb did not stain tissue cultured bovine
glomerular endothelial cells or mesangial cells, but did stain bovine
glomerular epithelial cell cultures. 305 did not stain MDCK cell
cultures. The binding of mAb 305 to glomeruli was investigated by
immunoelectron microscopy of rat renal tissue. In contrast to the
podocyte specificity on bovine glomerular cells in vitro, it was found
that the specificity of 305 expression on rat glomerular cells in vivo was
broader. No binding of mAb 305 was found outside the glomerulus in
the rat renal cortex. Podocytes, endothelial cells and capsular epithelial
cells expressed the 3W antigen most strongly. A lesser amount of
binding was found in the glomerular basement membrane. The mesan-
gium showed a little binding of mAb 305 and no binding at all was found
to other cortical structures. The 305 antigen in rat renal tissue was
found to be a glycolipid that migrated between the ganglioside markers
GM2 and GM1 by immunostaining of thin layer chromatogrnms. The
305 mAb has previously been shown to react with microvascular
pericytes, resting T-lymphocytes and cells of the brain, thyroid gland
and adrenal gland as well as various malignancies. The significance of
the tissue specific patterns of expression remains unclear and will be
understood only when the function of this ganglioside is elucidated.
Studies on the biology and pathology of the renal glomerulus
are increasingly turning to tissue culture of glomerular cells as
a means of understanding the roles of each glomerular cell type
in health and disease. Such studies have, however, been
hampered by the paucity of biochemical markers available to
facilitate identification and purification of these cells for studies
in vitro. Glomerular cells in vitro have been identified by
morphological and growth characteristics [1, 21 and, more
specifically, endothelial cells have been identified by binding of
antibodies to Factor VIII antigen and by uptake of acetylated-
LDL [3] while mesangial cells have been shown to express the
thy-l glycoprotein in vivo [4—6]. Mesangial cells have also been
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shown to contract in response to angiotensin II as well as other
agents [1], however, contractility bioassays are at best tedious
to perform and do not aid either quantification or purification of
these cells. The availability of a well characterized panel of
specific antibody markers of glomerular cells will aid the
unequivocal identification of each cell type.
The 305 mAb has previously been shown to react with
pancreatic islet cells, brain cells, adrenal medullary cells,
peripheral blood T-lymphocytes, and brain and retinal micro-
vascular pericytes [7—11]. In this communication we report the
characterization of the distribution of a mAb (305) defined
ganglioside antigen in the renal cortex.
Methods
Monoclonal antibodies
The 305 mAb was produced as previously described [11] by
immunizing (Balb/c x C57 B l)Fi hybrid mice with an homoge-
nate of neonatal rat brain followed by fusion of the splenocytes
with myeloma cells. The antibody was prepared for use as an
ascites fluid from Balb/c x CS7B 1 Fi hybrid mice. Ascites fluid
generally contained 8—14 mg of Ig per ml. The 305 hybridoma
line is now available through ATCC, cat# CRL 1418. The
negative control antibodies used were mAb ATCC # HBS7, an
IgGik antibody which binds to human 1gM-mu chain, was
obtained as a hybridoma cell line from the American Type
Culture Collection (ATCC) (Rockville, Maryland, USA) and
the mAb was produced as an ascites fluid in Balb/c mice. A
second control antibody, HISL-19 (1gM), with specificity to
human islet cells was similarly produced as an ascites fluid in
Balb/c mice.
Antisera
Rabbit anti-von Willebrand's Factor (Factor VIII antigen)
was purchased from Dako Corp (Carpenteria, California,
USA). Fluorescein conjugated goat anti-rabbit Ig was pur-
chased from Sigma Chemical Company (St. Louis, Missouri,
USA). Fluorescein conjugated goat anti-mouse IgG (Fc spe-
cific) and goat anti-mouse 1gM (,tt-chain specific)-rhodamine
conjugated was purchased from Cappel (Westchester, Pennsyl-
vania, USA).
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Isolation and tissue culture of glomerular cells
Glomerular cells were isolated and tissue cultured using a
modification of the method described by Ballerman [3]. Briefly,
the capsules of rat or bovine kidneys were removed and the
cortices were aseptically dissected off the medullae. The corti-
ces (5 to 10 g) were minced with scissors, pressed through a
sterile 140 m pore nitex mesh (Tetko, Elmsford, New York,
USA) and washed through with DMEM. The 140 j.m nitex
retentate was then passed through a 80 tm pore nitex mesh and
the retentate was then passed through a 140 m nitex mesh and
the glomeruli retained by the mesh were collected. The isolated
glomeruli were either immunostained at this stage or explanted
to establish cell cultures. All the cell cultures used in this report
were of bovine origin.
Glomerular cell cultures. Glomerular cell cultures were pro-
duced by digestion of glomeruli with 10 ml of a solution of 1
mglml collagenase (CLS4, 195 U/mg, Worthington Biochemical
Corp., Freehold, New Jersey, USA) in RPMI 1640 medium for
15 minutes, 37°C, gently agitating every five minutes. After
digestion, RPM! 1640 medium supplemented with 15% FCS
was added to 50 ml and the digested glomeruli were then
centrifuged at 500 x gmax for five minutes. The resultant pellet
was used to initiate mesangial cell cultures. The supernatant
was removed, recentrifuged at 1000 x g for 10 minutes and the
pellet so produced was resuspended in RPM! 1640 medium
containing 20% plasma derived horse serum (HyClone Labora-
tories, Logan, Utah, USA), penicillin 5 U/mi and streptomycin
5 g/ml. Cells were plated on human fibronectin (>95% pure,
New York Blood Center, New York, New York, USA) coated
100 mm plates at a density of 50 to 100 cells/mi. Four to five
hours after plating, non-adherent cells were removed by wash-
ing twice with DMEM after which endothelial cell growth
medium consisting of RPMI 1640 medium containing 20% horse
serum, and 1% endothelial cell growth factor (ECGF) prepared
from bovine brain [12] was added to the adherent cells and
changed at 48 hour intervals. Pure populations of both endo-
thelial and visceral epithelial cells (podocytes) were derived by
isolating clones through trypsinization in cloning rings and
propagation on fibronectin coated plates in RPM! 1640 + 1%
ECGF and RPMI 1640 + 20% FCS, respectively.
Glomerular mesangial cell cultures. Glomerular mesangial
cell cultures were initiated from the first pellet derived by
centrifugation after digestion of glomeruli. Cells were plated on
plastic petri dishes at approximately 100 cells/mI. Mesangial
cells were grown in RPM! 1640 medium containing 15% FCS.
After colonies of 300 to 500 cells were established, individual
clones were isolated with cloning rings, detached with a solu-
tion of trypsin/EDTA and propagated in RPM! 1640-15% FCS
on plastic plates.
Madin Darby Canine Kidney (MDCK) cells were obtained
from the ATCC, Cat# ATCC CCL 34. Cells were grown for
immunostaining as described below.
Endothelial cells were identified by cobblestone morphology
at confluence, uptake of acetylated LDL and staining with
antibodies to Factor VIII antigen. Podocytes were identified by
cobblestone morphology at confluence, negative staining for
Factor VIII antigen and positive staining with an antibody to
cytokeratin. Mesangial cells were identified by morphology
alone.
Indirect immunofluorescence
Frozen sections. Rat, mouse, human, calf and dog kidney
tissue were snap frozen in liquid nitrogen, and stored at —80°C
prior to use. Pieces of kidney tissue were embedded in OCT
compound, mounted on a chuck and 5 sm sections were cut
using a cryotome. The sections were picked up on a glass
microscope slide, air dried and stored at —80°C until used. The
frozen sections were either stained directly or after immersion
in acetone for five minutes at 20°C. Thirty microliters of
appropriately diluted first antibody were applied to the section
(mAbs diluted 1:100 in PBS-1% BSA; antisera diluted 1:50 in
PBS-l% BSA) and incubated for 30 minutes at 20°C; the
sections were then washed 3 x 5 minutes in PBS prior to
addition of the fluorescent anti-immunoglobulin. Thirty micro-
liters of the appropriate fluorescent anti-Ig was added to each
section and incubated for 30 minutes at 20°C. The sections were
then washed as before, the excess moisture removed, and a
coverslip mounted over the section with AFT systems mounting
medium (Calbiochem-Behring Corp., La Jolla, California, USA).
The sections were then viewed on a Leitz Dialux microscope
equipped with both phase contrast and fluorescence optics.
Isolated glomeruli. Giomeruli were resuspended in PBS-1%
BSA and aliquoted into silane treated (Sigma) glass tubes to
prevent sticking to the walls. The glomeruli were incubated
with 0.2 ml of first antibody diluted and incubated as above, the
glomeruli were then pelleted gently by centrifugation (300 x g,
10 mm) and washed 3 times by resuspension in PBS and
centrifugation. The glomeruli were similarly incubated with
fluorescent antibodies and incubated and washed as above. The
stained glomeruli were resuspended in 50 sl of PBS-l% BSA
and 20 1.d was placed on a glass slide, covered with a coverslip
and sealed with nail polish. The stained viable glomeruli were
immediately viewed and photographed on the microscope de-
scribed above.
Isolated glomerular cells. Isolated glomerular cells were
plated onto fibronectin (New York Blood Center, New York,
New York, USA) coated 8-well LabTek tissue culture chamber
glass slides (Miles Scientific; Naperville, Illinois, USA) and
incubated for two to three days before staining. Double staining
with 3G5 and 0X7 was performed simultaneously; the first
antibodies were mixed together such that both antibodies were
at a final dilution of 1:100 in DMEM containing 10% neonatal
bovine serum. The first antibody mixture (200 d) was applied to
each well and incubated as above, the cells were then washed
by flooding the wells with DMEM and then aspirating off the
DMEM three times. The fluorescent antibodies were also
applied simultaneously and incubated and washed as above.
After staining, the cells were lightly fixed by applying 200 d of
a solution of 5% glacial acetic acid, 70% methanol and 25%
water at 4°C for one minute followed by washing as above with
a final wash in PBS. The plastic wells and gasket were then
removed, a coverslip applied and viewed as above. Double
staining with mAb and antisera to Factor VIII was performed
by single staining with the mAb first, lightly fixing and perme-
abilizing the cells as above, and then staining with anti-Factor
VIII antisera.
Electron microscopy
Tissue fixation. Wistar Furth rats (Harlan Sprague-Dawley,
Indianapolis, Indiana, USA) were anaesthetized with a large
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dose (200 mg/kg) of Amytal (Eli Lilly Inc., Indianapolis, Indi-
ana, USA) and fixed by critical vascular perfusion through the
aorta via the left ventricle of the heart. Two hundred milliliters
of normal saline was perfused through the animal, followed by
200 ml of freshly prepared aldehyde fixative (4% paraformalde-
hyde and 0.5% glutaraldehyde in a 0.1 M phosphate buffer at pH
7.2) and 50 ml of PBS containing 50 mai glycine to end the
fixation and quench residual aldehyde groups as described by
Keijaschki and Parquhar [13]. Harvested tissues were cut into
small blocks and the cortex was dissected away from the
medulla. The cortical tissue was placed in PBS at 4°C until
processed.
Tissue processing and immunostaining. Post-fixation with
osmium tetroxide was not performed prior to immunostaining.
The tissue blocks were dehydrated in acetone and embedded in
Lowicryl HM2O (non-polar) resin (Polysciences Inc., War-
rington, Pennsylvania, USA). Thin sections were cut on an
LKB NOVA ultramicrotome (LKB, Bromma, Sweden) and
placed on nickel grids. They were then soaked in PBS-1% OVA
for 30 minutes at 20°C. The grids were then soaked in a 1:20,000
dilution of 3G5 or control antibody HB57 in PBS-l% OVA for
two hours at 20°C. The grids were then jet washed with PBS-l%
OVA, soaked in PBS-l% OVA three times for five minutes each
at 20°C and then jet washed again; the fluid drop remaining on
the grid was blotted off before proceeding to the next step,
taking care not to allow the tissue to dry. The grids were then
soaked in 10 nm colloidal gold conjugated goat anti-mouse
1gM-p. chain specific (Janssen Life Science Products, Piscat-
away, New Jersey, USA) diluted 1:30 in PBS-l% OVA for one
hour at 20°C. The grids were then jet washed in PBS-1% OVA,
washed 3 x 5 minUtes as before, jet washed again in distilled
water and air dried. They were then exposed to osmium
tetroxide fumes for 45 minutes, and then stained with uranyl-
acetate and lead citrate following the conventional procedure.
The stained tissues were then viewed with a Phillips 301
transmission electron microscope.
Quant jfication of3G5 binding. Photographs of four randomly
selected glomeruli representing 3G5 and control (HISL-l9)
stained tissue sections were used to quantify specific binding of
3G5 to glomerular structures. The visible structures were
categorized into podocyte, glomerular basement membrane,
endothelium, mesangium, capsular epithelium and cortical tu-
bule compartments. Colloidal gold particles were counted in
each of these compartments and the area of these compart-
ments was estimated by planimetry using a digitizing tablet
linked to an NEC powermate 2 personal computer running
Sigma Scan software (Jandel Scientific, Corte Madera, Califor-
nia, USA).
The numbers of gold particles counted were normalized to
represent equivalent areas by dividing the number of particles
in a compartment by the area of the compartment to yield the
particle density. The specific 3G5 binding to each compartment
was calculated by subtracting the particle density of HISL-19
from the 3G5 particle density for each compartment.
Extraction of 3G5 antigen from renal tissue
Glycolipid extraction was performed essentially as described
by Svennerholm and Fredman [14]. Ten grams of rat kidney
was homogenized in 21 ml of distilled water using a polytron
homogenizer operating at full speed. The homogenate was then
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added to 240 ml of methanol and 120 ml of chloroform and
stirred for 30 minutes at 20°C. The mixture was then centrifuged
at 300 x g for 20 minutes at 4°C. The supernatant was retained
on ice, the pellet was homogenized into 30 ml of water,
re-extracted with 240 ml of methanol and 120 ml of chloroform
and centrifuged as above. The supernatants were combined and
water was added (with gentle mixing) to achieve a chloroform:
methanol:water ratio of 1:2:1.4. This mixture was placed in a
separation funnel and left for 16 hours to separate into two
phases. The upper phase was removed and retained on ice while
the lower phase was repartitioned after addition of 0.5 volumes
of methanol and 0.2 volumes of 0.01 M aqueous KCI. The
combined upper phases were dried by rotary evaporation,
resuspended in 0.1 M aqueous potassium chloride and subjected
to bonded phase extraction chromatography on C-18 SepPak
cartridges (Waters, Milford, Massachusetts, USA) as described
by Williams and McCluer [15].
Thin layer chromatography and immunodetection of 3G5
antigen
The glycolipids obtained as described above were spotted
onto aluminium backed high performance thin layer chromatog-
raphy (HPTLC) plates (E.M. Sciences, distributed through
VWR Scientific, Boston, Massachusetts, USA) and subjected
to ascending chromatography in a tank equilibrated with 100 ml
of chloroform:methanol:0.25% aqueous KC1 (5:4:1). The TLC
plate was then removed from the tank, air dried and cut into
strips. The strips were then immunostained by a modification of
the method of Magnani et al [16]. After immersion in a saturated
solution of polyisobutylmethacrylate (Polysciences Inc.) in
hexane for 90 seconds and air drying, the strips were soaked in
an excess of PBS-3% BSA for one hour at 20°C, after which
they were incubated with 4 ml of a 1:100 dilution of 3G5 or
control antibody in PBS-3% BSA for two hours at 20°C. The
strips were washed in PBS-3% BSA 3 x 5 minutes prior to
incubation for one hour at 20°C with 4 ml of horseradish
peroxidase conjugated rabbit anti-mouse Ig (Dako Corp.) di-
luted 1:100 in PBS-3% BSA. After rewashing the strips, they
were incubated for a further one hour at 20°C with a 1:100
dilution of swine anti-rabbit Ig (Dako Corp.) in PBS-3% BSA.
After washing again, a color reaction was initiated by adding a
solution of 50 mg of 4-chloro-1-napthol in 50 ml of 50 mrs Tris
buffer, pH 7.4, containing 0.012% hydrogen peroxide. The
mobility of immunostained bands was compared with the mo-
bilities of authentic ganglioside standards purified from bovine
brain (Bachem Inc., Torrance, California, USA).
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Fig. 1. Double indirect inimunofluorescence on frozen sections of rat kidney. (a) 3G5 stained glomeruli; (b) Factor VIII stain on same glomeruli
in (a); (c) 3G5 stained glomerulus; (d) OX-7 stain on glomerulus in (c).
Table 2. Staining of tissue cultured renal cells w
antibody 3G5
ith monoclonal
Species mAb 3G5 mAb HB57





Mesangial cells Bovine — —
Endothelial cells Bovine — —
MDCK Canine - —
Results
The results of the immunofluorescence screening experi-
ments are summarized in Table I. The mAb 3G5 was found to
bind to renal cortical structures in frozen sections of kidney
from a number of mammalian species. In human sections, the
glomerulus showed extensive staining only when immersed in
acetone for five minutes prior to staining with mAb 3G5.
Acetone-treated human kidney sections showed 3G5 positivity
on the juxtaglomerular apparatus and glomerular mesangial
cells. Frozen sections of human kidney stained with mAb 3G5
without prior acetone treatment showed staining of the juxta-
glomerular apparatus only. Frozen rat kidney sections stained
with 3G5 regardless of prior exposure to acetone, however,
pre-exposure of these sections to acetone did increase the
intensity of staining. Frozen sections of calf kidney were also
only stained with mAb 3G5 after acetone pretreatment; under
these conditions strong staining of the proximal convoluted
tubules was seen.
In an attempt to further define the cellular specificity of mAb
3G5 staining, double indirect immunofluorescence experiments
were performed utilizing mAb 3G5 and a rabbit antiserum
reacting with Factor VIII antigen on frozen sections of rat
kidney. The results of these double staining experiments are
shown in Figure 1, from which it can be seen that the 3G5
staining of the glomerulus is more extensive than the staining
with anti-Factor VIII antisera. These results indicate that the
distribution of mAb 3G5 staining over the glomerulus cannot
simply be due to endothelial cell staining as the distribution of
3G5 antigen is more extensive than the endothelial cell marker
(Factor VIII antigen). Double staining with 3G5 and OX-7
(Thy-i antigen) showed that 3G5 staining exceeded the limits of
OX-7 staining indicating that mesangial binding alone could not
account for the 3G5 binding to glomeruli.
Bovine glomeruli were isolated and used to initiate tissue
cultures of renal glomerular cells for immunofluorescence stain-
ing. The results of immunofluorescent staining with mAb 3G5
on tissue cultured bovine glomerular cells are summarized in
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Fig. 2. Immunofluorescent staining of subconfluent tissue cultured cells. (a) 3G5 stained podocytes; (b) 3G5 stained endothelial cells; (C)
anti-factor VIII stained podocytes; (d) anti-factor VIII stained endothelial cells.
Table 2. The mAb 3G5 did not bind to tissue cultured glomer-
ular endothelial cells, human podocytes or to mesangial cells
but did bind to bovine glomerular epithelial cells. mAb 3G5 did
not stain the canine renal epithelial cell line, MDCK. An
example of the staining on tissue cultured epithelial cells is
shown in Figure 2.
The localization of 3G5 antigen in the glomeruli of rats was
studied by immunoelectron microscopy using colloidal gold
conjugated anti-mouse 1gM and mAb 3G5. By electron micros-
copy it was clear that gold particles were abundant on
podocytes, especially on the cytoplasmic processes and pedi-
cels (secondary processes; Fig. 3). Additionally, gold particles
were observed on endothelium, glomerular basement mem-
brane, and capsular epitheliurn. Few gold particles were asso-
ciated with the mesangium. The surrounding cortical tubules
did not show any binding of 3G5. The binding of the control
antibody (HISL-19) to any renal cortical structure was negligi-
ble. Quantification of gold particles on glomerular structures
was performed and the results are shown in Figure 4. The
binding of 3G5-associated gold particles was normalized to area
of each cortical compartment and expressed as particles/m2.
The results indicate the following rank order of 3G5 binding:
podocytes (17.7lIjsm2) <endothelium (11 .O2/m2) < capsular
epithelium (7.481p.m2) <glomerular basement membrane (3.0/
m2) < mesangium (0.95/p.m2) < cortical tubules (0.OIp.m2).
The nature of the 3G5 antigen was investigated by preparing
glycolipid extracts of rat kidney tissue. Duplicate aliquots of the
kidney glycolipid extract were subjected to thin layer chroma-
tography on aluminium backed HPTLC plates and then stained
with mAb 3G5 and a control antibody by an indirect immuno-
peroxidase method. The 3G5 antigen was found to migrate
between the purified ganglioside markers GM1 and GM2 (Fig.
5).
Discussion
The 3G5 antigen in the kidney was shown to be a glycolipid
which migrated between the ganglioside markers GM1 and GM2
on HPTLC and is probably a ganglioside itself, The binding of
mAb 3G5 to pancreatic islet cells has been demonstrated to be
neuraminidase sensitive, insensitive to Pronase and can be
extracted into organic solvents [171. Furthermore, the 3G5
antigen of pancreatic islet cells has been shown to be a
ganglioside which migrates between GM! and GM2 on HPTLC
[9]. The 3G5 antigen therefore appears to be a ganglioside
which, by definition, is a glycolipid which contains sialic acid.
The monoclonal antibody 3G5 has been shown to react with
renal glomerular structures in a number of mammalian species
in this report. Double staining experiments have shown that the
distribution of the 3G5 antigen over the rat glomerulus is
markedly different from the distribution of Factor VIII antigen.
These results suggest that glomerular endothelial cells cannot
account for all of the expression of the 3G5 antigen in the
glomerulus as the endothelial marker, Factor VIII antigen, has
a much more circumscribed distribution than the 3G5 antigen.
Similarly, 3G5 staining was found to be more extensive than the
distribution of the Thy-i antigen in the glomerulus. Staining of
tissue cultured glomerular cells and renal tissue prepared for
electron microscopy was performed to determine which gb-
merular cells expressed 3G5 antigen. Only cell cultures of
bovine glomerular epithelium were found to express the 3G5
antigen, the mesangial cell and endothelial cell cultures were
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Fig. 3. Immunoelectron microscopic visualization of antibody binding to rat renal glomeruli. A, B, C: 3G5. D, E, F: HISL 19 (control); A and D,
glomerulus; B and E, mesangium; C and F, tubular epithelium and brush border. Abbreviations are: T, tubule; C, Bowman's capsule; Us, urinary
space; P, podocyte; GBM, glomerular basement membrane; E, endothelium; M, mesangium.
glomeruli in frozen sections of bovine kidney but did stain
tubules. This may indicate that the 3G5 ganglioside expression
is activated in glomerular epithelial cells (podocytes) when
removed from the in vivo environment and grown in vitro.
Alternatively, it is possible that cells of tubular epithelial origin
may contaminate the glomerular podocyte culture and that the
observed 3G5 reactivity is due to expression of the ganglioside
antigen on tubular epithelial cells. Some evidence against
reactivity with contaminating tubular epithelial cells is found in
the observation that the MDCK renal epithelial cell line does
not express the 3G5 ganglioside.















0 5 10 15 20
Particles/jim2
Fig. 4. Quant{fication of3G5 associated colloidal gold particles bound
to glomeruli. Symbols are: (solid bar) 3G5 binding; (crosshatched bar)
control antibody binding. For density of 3G5-associated colloidal gold
particles, the numerical value of the particle density is given over each
bar.
rat kidney sections with mAb 3G5 revealed that the 3G5 antigen
is found principally on the podocyte in vivo (Fig. 4). Addition-
ally, gold particles were observed on endothelium, glomerular
basement membrane, and capsular epithelium. Small amounts
of gold were associated with the mesangium. The surrounding
cortical tubules did not show any binding of 3G5. The binding of
the control antibody (HISL-l9) was negligible. The results
indicated the following rank order of 3G5 binding: podocytes <
endothelium < capsular epithelium < glomerular basement
membrane < mesangium < cortical tubules. It is interesting to
note that the capsular epithelium, from which podocytes are
derived developmentally, expresses less 3G5 immunoreactivity
than the podocytes. This suggests that the differentiation of
podocytes from capsular epithelial cell during development is
accompanied by a quantitative up-regulation of the genes re-
sponsible for 3G5 expression.
The binding to endothelium observed by immunoelectron
microscopy of rat kidney apparently contradicts the lack of 3G5
binding to bovine endothelium in tissue culture. The observed
3G5 binding to rat endothelium in vivo but not to bovine
endothelium in vitro or in vivo suggests that the expression of
the 3G5 ganglioside has both cell type and species specificity.
The genetic control of phenotypic expression of ganglioside
antigens is both interesting and complex as gangliosides being
glycosphingolipids do not have structural genes which direct
their synthesis. The synthesis of glycosphingolipids is effected
through the coordinate expression of genes for enzymes in-
volved in the synthesis of ceramide and a number of glycosyl
transferases and in turn through the coordination of the activi-
ties of these enzymes.
Consequently the expression of 3G5 immunoreactivitywould
require that all the genes and all the enzyme activities be
expressed in an appropriately coordinated manner. As biosyn-
thesis of progressively more complex gangliosides involves
extension of the sugar chain of simpler gangliosides, these
simpler gangliosides must be biosynthesized as precursors of
Fig. 5. Identification of the 3G5 ganglioside antigen in rat kidney
extracts separated by high-performance thin layer chromatography.
Abbreviations are: 3G5, staining of TLC with mAb 3G5; C, staining
with control antibody; monosialoganglioside markers, GM2 and GM1;
disialoganglioside markers, GD1a and GDIb; trisialoganglioside marker,
GTIb.
the final molecule, Therefore the lack of 3G5 immunoreactivity
may signify the lack of expression of only one of the required
genes, all of the required genes, or any intermediate number of
those genes.
Podocytes are known to have an unusually high negatively-
charged cell surface, termed the "epithelial polyanion," which
has a sialic acid-rich nature [18—211. A single sialoglycoprotein,
termed "podocalyxin," has been reported to account for 85 to
95% of glomerular sialic acid labeled by periodate oxidation
followed by tritiated borohydride reduction [22]. On this basis it
has been proposed that "podocalyxin" is the major component
of the epithelial polyanion 1221. The presence of an intact
"epithelial polyanion" is believed to be crucial for the mainte-
nance of podocyte structure as its absence in certain glomerular
diseases [23, 24] and in glomerular ontogeny [25] is associated
with distorted foot process and filtration slit pore organization.
Negatively charged molecules intrinsic to the filtration barrier
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across the glomerular basement membrane; consequently the
epithelial cell, being rich in sialic acid, may participate in charge
selective filtration. The 3G5 ganglioside antigen has been local-
ized principally to the podocyte and endothelium in vivo and
may be a component of the "epithelial polyanion," and thus
may have a role in permselectivity.
The 3G5 antigen is protease insensitive as it is not a protein,
and can be used to stain trypsinized cells and thus facilitate
quantification either by visual counting with the aid of a
microscope or by flow cytometry. These properties should
allow purification of podocytes by fluorescence-activated cell
sorting (FACS). The 3G5 antigen has been shown to be ex-
pressed on microvascular pericytes in both the retina and brain,
and the 3G5 mAb was used to both quantitate and purify
pericytes by FACS [7]. The 3G5 antigen in retinal pericytes was
also found to be a glycolipid migrating between GM1 and GM2
on HPTLC in that study.
In addition to being a marker of bovine glomerular podocytes
in vitro, the 3G5 mAb may be of utility in elucidating the
molecular composition/abnormalities of glomerular lesions in
renal diseases such as diabetic nephropathy in which podocyte
foot process width has been reported to be abnormal [26] and an
accumulation of sialic acid in the glomeruli has been reported
[27].
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Appendix. Abbreviations
PBS —Phosphate buffered saline, pH 7.4
DMEM — Dulbecco's modified Eagle's medium
FCS — Fetal calf serum
BSA — Bovine serum albumin
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